749
Participants
Start Date
September 30, 2007
Primary Completion Date
May 31, 2009
Study Completion Date
May 31, 2009
E2/LNG oral (Wellnara, BAY86-5029)
Patients in daily life treatment receiving Wellnara according to local drug information.
Many Locations
Lead Sponsor
Bayer
INDUSTRY